About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 493138, 6 pages
http://dx.doi.org/10.1155/2013/493138
Review Article

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?

1Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, USA
2EpiVax, Inc., 146 Clifford Street, Providence, RI, USA
3Genethon, Evry, France
4University Pierre and Marie Curie, Paris, France

Received 12 July 2013; Accepted 17 October 2013

Academic Editor: Darren R. Flower

Copyright © 2013 Anne S. De Groot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anne S. De Groot, Leslie Cousens, Federico Mingozzi, and William Martin, “Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?,” Clinical and Developmental Immunology, vol. 2013, Article ID 493138, 6 pages, 2013. doi:10.1155/2013/493138